Werewolf Therapeutics, Inc. (HOWL) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -10.6M | -11.02M | -15.16M | -15.16M | -18.95M | -14.25M | -12.46M | -14.18M | -15.3M | -4.58M | -7.21M | -10.92M | -9.9M | -11.87M | -14.47M | -303K | -13.95M | -12.67M | -12.42M | -10.46M |
| Operating CF Margin % | - | - | - | - | - | - | - | -1240.33% | -2061.59% | -305.46% | -122.23% | -135.14% | -221.73% | -162.98% | -291.19% | -7.3% | - | - | - | - |
| Operating CF Growth % | 44.07% | 22.65% | -21.62% | -6.96% | -23.87% | -210.84% | -72.89% | -29.81% | -54.55% | 61.37% | 50.19% | -3504.29% | 29.05% | 6.34% | -16.55% | 97.1% | -90.43% | -110.9% | - | - |
| Net Income | -13.53M | -8.38M | -16.37M | -17.98M | -18.09M | -20.4M | -16.67M | -17.25M | -16.19M | -12M | -8.29M | -5.1M | -11.98M | -11.93M | -11.94M | -14.59M | -15.34M | -17.87M | -13.76M | -10.92M |
| Depreciation & Amortization | 398K | 400K | 402K | 406K | 426K | 442K | 454K | 454K | 464K | 460K | 445K | 434K | 425K | 417K | 404K | 185K | 98K | 48K | 67K | 62K |
| Stock-Based Compensation | 0 | 1.21M | 0 | 1.79M | 2.01M | 1.91M | 2.01M | 2.6M | 2.31M | 1.87M | 2.1M | 1.93M | 2.11M | 1.94M | 1.94M | 1.78M | 1.75M | 1.3M | 1.48M | 781K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.81M | -3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.07M | -1.07M | 752K | 694K | -2.86M | 3.34M | 1.37M | 978K | 468K | 3.26M | 3.74M | 409K | -612K | 653K | 295K | 840K | -291K | 662K | -1.34M | 1.31M |
| Working Capital Changes | 1.47M | -3.19M | 60K | -75K | -432K | 458K | 380K | -962K | -2.34M | 4.63M | -2.09M | -8.6M | 163K | -2.95M | -5.16M | 11.49M | -160K | 3.19M | 1.13M | -1.69M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 464K | 81K | 230K | 575K | 4.56M | 1.02M | -672K | 673K | -2.63M | -2.08M | -2.22M | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 672K | 0 | 2.63M | 2.08M | 2.22M | 0 | 0 | 0 | 0 |
| Change in Payables | 1.92M | -3.94M | 0 | 1.02M | 0 | 0 | 0 | 0 | -2.47M | -4.58M | -104K | -616K | 903K | -105K | -910K | 806K | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | -123K | -3K | -17K | -111K | -198K | -221K | -182K | -168K | -518K | -1.95M | -1.11M | -28K | -272K | -102K | -111K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -123K | -3K | -17K | -111K | -198K | -221K | -182K | -168K | -518K | -1.95M | -1.11M | -28K | -272K | -102K | -111K |
| CapEx % of Revenue | - | - | - | - | - | - | - | 1.49% | 14.96% | 13.19% | 3.75% | 2.25% | 3.76% | 7.11% | 39.32% | 26.78% | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 2.37M | 3.27M | 388K | 0 | 2.55M | -6K | -9.72M | 20.26M | 9.07M | 41K | 692K | 48.62M | 1.26M | 11.08M | 3.42M | 159K | 38K | -276K | 110.2M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 2.37M | 0 | 388K | 0 | 0 | -6K | 0 | 20.25M | 8.88M | 182K | 642K | 8.62M | 1.43M | 11.11M | 3.65M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 3.27M | 0 | 0 | 2.55M | 0 | -9.72M | 12K | 191K | -141K | 50K | 0 | -174K | -32K | -238K | 159K | 38K | -276K | 110.2M |
| Net Change in Cash | -10.6M | -8.66M | -11.88M | -14.78M | -18.95M | -11.83M | -12.47M | -23.91M | 4.85M | 4.08M | -7.18M | -10.41M | 38.56M | -11.13M | -5.35M | 2M | -13.82M | -12.91M | -12.79M | 99.63M |
| Free Cash Flow | -10.6M | -11.02M | -15.16M | -15.16M | -18.95M | -14.38M | -12.46M | -14.19M | -15.41M | -4.78M | -7.43M | -11.1M | -10.07M | -12.39M | -16.43M | -1.41M | -13.98M | -12.95M | -12.52M | -10.57M |
| FCF Margin % | - | - | - | - | - | - | - | -1241.82% | -2076.55% | -318.65% | -125.98% | -137.4% | -225.49% | -170.09% | -330.5% | -34.09% | - | - | - | - |
| FCF Growth % | 44.07% | 23.31% | -21.59% | -6.83% | -22.98% | -200.54% | -67.79% | -27.84% | -53.07% | 61.39% | 54.77% | -685.22% | 27.99% | 4.3% | -31.21% | 86.62% | -90.48% | -115.1% | - | - |
| FCF per Share | -0.21 | -0.24 | -0.33 | -0.34 | -0.42 | -0.32 | -0.29 | -0.33 | -0.37 | -0.13 | -0.21 | -0.31 | -0.29 | -0.40 | -0.55 | -0.05 | -0.51 | -0.47 | -0.46 | -0.60 |
| FCF Conversion (FCF/Net Income) | 0.78x | 1.32x | 0.93x | 0.84x | 1.05x | 0.70x | 0.75x | 0.82x | 0.94x | 0.38x | 0.87x | 2.14x | 0.83x | 0.99x | 1.21x | 0.02x | 0.91x | 0.71x | 0.90x | 0.96x |
| Interest Paid | 0 | 0 | 790K | 0 | 773K | 781K | 789K | 878K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |